Photo from wikipedia
Several studies have reported a high risk of local disease recurrence (LR) and locoregional disease recurrence (LRR) in patients with breast cancer after neoadjuvant chemotherapy (NCT) and breast‐conserving therapy (BCT).… Click to show full abstract
Several studies have reported a high risk of local disease recurrence (LR) and locoregional disease recurrence (LRR) in patients with breast cancer after neoadjuvant chemotherapy (NCT) and breast‐conserving therapy (BCT). The objective of the current study was to identify potential risk factors for LR and LRR after NCT and BCT.
Keywords:
cancer;
locoregional disease;
disease recurrence;
risk
Journal Title: Cancer
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Cancer
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!